Science & Innovation Forums

These live and on-demand programs are presented by companies serving the AABB community and target a critical need in the field that can be addressed by the sponsor’s solutions technology. Registration is complimentary to all. Continuing education credit is not available.


The Impact of Red Blood Cell Transfusions on Biomarkers of Hemorrhagic Shock and Traumatic Brain Injury
Presented by Hemanext®, an AABB Premium Corporate Partner
Held: May 5, 2022 (on-demand available)

Benefits of Early Fibrinogen Supplementation & Experience with Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT® Fibrinogen Complex)
Presented by Cerus Corporation
Held: April 28, 2022 (on-demand available)

Cornell and UCLA Medical Centers Assess Safety and Efficacy of Pathogen Reduced (PR) Platelets
Presented by Cerus Corporation
Held: March 24, 2022 (on-demand available)

Implementing Pathogen Reduced Platelets: Transfusion Safety Officer (TSO) Perspectives from a Leading Pediatric Institution and Large Hospital Network
Presented by Cerus Corporation
Held: November 4, 2021 (on-demand available)

Assessing FDA Bacterial Guidance Strategies: Perspectives from Canadian Blood Services, the American Red Cross, and OneBlood
Presented by Cerus Corporation
Held: September 9, 2021 (on-demand available)

Support the AABB Community through Corporate Sponsored Education
Interested in sponsoring a forum? If so, please reach out to us at mboraz@aabb.org.